Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01880034 · ClinicalTrials.gov registry record
Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 18
- Enrollment target
NCT01880034: Completed study, sponsored by University of Wisconsin, Madison.
NCT01880034 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01880034 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Significant data exists to suggest that lipid emulsion administration in the setting of local anesthetic toxicity has the potential to be life-saving. Unfortunately, a variety of potential barriers exist to routine lipid emulsion administration for those performing regional anesthesia including drug availability, drug cost and drug location. Inadequate training or lack of established protocols also have the potential to negatively impact patient outcomes. A previous study by Toledo et al (Availability of lipid emulsion in United States obstetric units. Anesth Analg 2013;116:406-408.) evaluated lipid emulsion availability on obstetric units and found that it was nearly universally available. The Accreditation Council for Graduate Medical Education (ACGME) publishes a list of contact information for each anesthesia institution that engages in resident training. Investigators will contact these institutions by phone or email to obtain contact information for their regional anesthesia program director. In the absence of a program director, investigators will send a survey and consent information via email to the faculty physician most involved in regional anesthesia. Survey completion instructions (survey itself to be completed on Qualtrics Survey Hosting Service) and copy of the study consent form will be attached to the initial contact email. The study consent form will contain a description of the study itself. Survey participants will be allowed time to complete their survey in private at their discretion. Non-responders will receive two follow-up emails at one month intervals.
Primary Outcome
Survey options include 1. Yes, lipid emulsion is available in the room where regional anesthesia is performed. 2. Yes, lipid emulsion is available in a near-by pharmacy 3. Yes, lipid emulsion is available in a central pharmacy 4. No, lipid emulsion is not available in all locations where regional anesthesia is performed
Interventions
- OTHER Lipid Emulsion Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-12 |
What the finished NCT01880034 record still lists
NCT01880034 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Lipid Emulsion Survey is the first listed.
NCT01880034 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01880034 about?
NCT01880034 is a clinical study titled "Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments". Significant data exists to suggest that lipid emulsion administration in the setting of local anesthetic toxicity has the potential to be life-saving. Unfortunately, a variety of potential barriers exist to routine lipid emulsion administration for those performing regional anesthesia including drug...
What is the current status of trial NCT01880034?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2013-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01880034?
The interventions under investigation include: Lipid Emulsion Survey (OTHER).
Who is sponsoring clinical trial NCT01880034?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia